Print

 

The following pharmaceutical products of Orion are marketed in the UK by Orion Pharma (UK) Ltd: 

 Stalevo ® for Parkinson's disease

 Comtess ® for Parkinson's disease

 Eldepryl ®  for Parkinson's disease

 Indivina ® for menopausal symptoms

 Tridestra ® for menopausal symptoms

 Fareston ® for breast cancer

 Frusene ® diuretic

 Methotrexate ® for rheumatoid arthritis and severe psoriasis

 Easyhaler range ® for asthma

 Vantas ® for prostate cancer

Sandrena ® for meopausal symptoms

Kentera ® for overactive bladder 

Patient information leaflet

Summary of product characteristics (238 KB)

 

Comtess®

Patient information leaflet

Summary of product characteristics

 

Eldepryl®

Patient information leaflet

Summary of product characteristics

 

Indivina®

Patient information leaflet

Summary of product characteristics

 

Tridestra®

Patient information leaflet

Summary of product characteristics

 

Fareston®  

Patient information leaflet

Summary of product characteristics

 

Frusene®

Patient information leaflet

Summary of product characteristics

 

Methotrexate®

Summary of product characteristics (2.5 mg tablets)

Summary of product characteristics (10 mg tablets)

 

Vantas®

Patient information leaflet (50 mg implant)

Summary of product characteristics (50 mg implant)

 Sandrena®

Summary of product characteristics (0.5 mg gel)

Summary of product characteristics (1.0 mg gel)

Patient information leaflet

 

Kentera®

Summary of product characteristics (Kentera oxybutynin transdermal patch)

Patient information leaflet (Kentera oxybutynin transdermal patch)

Updated 14 February 2011